Sutro Biopharma (STRO) Shares Outstanding (Weighted Average) (2016 - 2025)

Sutro Biopharma's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $8.5 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 9.84% year-over-year to $8.5 million; the TTM figure through Dec 2025 stood at $8.5 million (up 9.84% YoY), while the FY2025 annual figure was $8.5 million, up 9.84% from the prior year.
• Shares Outstanding (Weighted Average) came in at $8.5 million for Q4 2025 at Sutro Biopharma, down from $84.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $84.9 million in Q3 2025 to a low of $7.7 million in Q4 2024.
• A 5-year average of $55.1 million and a median of $54.7 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 97.89% in 2021 and plunged 87.14% in 2024, its largest moves.
• Sutro Biopharma's Shares Outstanding (Weighted Average) stood at $46.1 million in 2021, then rose by 10.02% to $50.7 million in 2022, then grew by 18.57% to $60.2 million in 2023, then slumped by 87.14% to $7.7 million in 2024, then climbed by 9.84% to $8.5 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $8.5 million, $84.9 million, and $83.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison